Scientific Sessions 2025  /  Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies  /  Early TAVR Trial: Latest Updates of Early TAVR in Severe Asymptomatic Aortic Stenosis Patients
Logo

American Heart Association

  63
  0

Final ID:

Early TAVR Trial: Latest Updates of Early TAVR in Severe Asymptomatic Aortic Stenosis Patients

  • Genereux, Philippe  ( Gagnon Cardiovascular Institute , Morristown , New Jersey , United States )
  • Leon, Martin  ( COLUMBIA UNIVERSITY MEDICAL CTR , New York , New York , United States )
  • Mack, Michael  ( Baylor heart Hospital , Plano , Texas , United States )
  • Hahn, Rebecca  ( COLUMBIA UNIVERSITY , New York , New York , United States )
    • Author Disclosures:
    Philippe Genereux: DO have relevant financial relationships ; Consultant:Edwards:Active (exists now) ; Consultant:piCardia:Active (exists now) | Martin Leon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Individual Stocks/Stock Options:Ancora:Past (completed) ; Individual Stocks/Stock Options:Cathworks:Active (exists now) ; Research Funding (PI or named investigator):Edwards:Active (exists now) | Michael Mack: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Other (please indicate in the box next to the company name):Carmat- Corporate board:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Rebecca Hahn: DO have relevant financial relationships ; Speaker:Abbott Structural:Past (completed) ; Speaker:Philips Healthcare:Active (exists now) ; Speaker:Edwards Lifescience:Active (exists now) ; Speaker:Baylis Medical:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
TAVR vs. SAVR in Low-Risk Aortic Stenosis Patients: 5-Year Outcomes Unveiled for Evolut Low-Risk

Reardon Michael, Forrest John, Popma Jeffrey, Tchetche Didier

Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation: MATTERHORN Trial

Baldus Stephan, Doenst Torsten, Von Bardeleben Ralph Stephan, Bleiziffer Sabine, Chikwe Joanna

More abstracts from these authors:
Next Generation for Transcatheter Innovations: Future Breakthroughs

Granada Juan, Leon Martin, Mack Michael

Beyond the Guidelines: Debate: Severe Asymptomatic Aortic Stenosis Patients Should Get TAVR

Pibarot Philippe, Genereux Philippe, Szerlip Molly, Hahn Rebecca, Boskovski Marko, Leon Martin, Hamilton Barbara

You have to be authorized to contact abstract author. Please, Login
Not Available